Subtype
Malignant Retinal Neoplasm
CI-CAN-00001173Explore in graph →
15 active trials1 approved drugs2 evidence items
- NCIt
- C3216
Loading cancer entity…
Subtype
CI-CAN-00001173Explore in graph →
Clinical trials
111 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (16)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00110110 | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma | unknown | Phase 2 | 71 | The Hospital for Sick ChildrenOTHER | 4 | Apr 17, 2024 | clinicaltrials |
| NCT04990271 | A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma | unknown | Phase 2 | 92 | Chengdu Kanghong Biotech Co., Ltd.INDUSTRY | 1 | Aug 4, 2021 |
| clinicaltrials |
| NCT00906113 | Intra-arterial Chemotherapy for Children With Retinoblastoma | unknown | Phase 1 / Phase 2 | 10 | Hadassah Medical OrganizationOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT01899066 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | unknown | Phase 2 | 20 | Sun Yat-sen UniversityOTHER | 1 | May 13, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Apr 17, 2024source: clinicaltrials